Author/Authors :
Pourgholi, Leyla Department of Molecular Pathology - Tehran Heart Center - Tehran University of Medical Sciences, Tehran , Goodarzynejad, Hamidreza Department of Cardiac Research - Tehran Heart Center - Tehran University of Medical Sciences, Tehran , Ziaee, Shayan Department of Molecular Pathology - Tehran Heart Center - Tehran University of Medical Sciences, Tehran , Zare, Elmira Department of Cardiac Research - Tehran Heart Center - Tehran University of Medical Sciences, Tehran , Jalali, Arash Department of Cardiac Research - Tehran Heart Center - Tehran University of Medical Sciences, Tehran , Boroumand, Mohammadali Department of Molecular Pathology - Tehran Heart Center - Tehran University of Medical Sciences, Tehran
Abstract :
Background: Studies on the association between the prothrombin G20210A variant and coronary artery disease (CAD) risk
are inconclusive. This study aimed to investigate the possible association between the G20210A variant in the prothrombin
gene and documented CAD and its severity.
Methods: This study enrolled 1460 patients who were consecutively admitted for elective coronary angiography. Via the
standard angiographic techniques, coronary angiographies were done and the presence and severity of CAD were determined
through the clinical vessel score and the Gensini score. Prothrombin G20210A genotypes were identified using PCR-RFLP.
Results: This cross-sectional study was performed on 953 men and 507 women at a mean age of 58.21±10.33 years. The
median and the interquartile range for the Gensini score were not statistically significantly different between the wild (GG)
and mutant (AA+GA) genotypes (P=0.440). The association between the G20210A polymorphism and the severity of CAD
with respect to the vessel score also showed no significant linear trend of higher numbers of diseased vessels (P= 0.765 for the
Mantel–Haenszel test of linear trend) in the AA+GA genotype as compared with the GG genotype.
Conclusion: Our data failed to confirm the hypothesis that the G20210A variant mutation may be a significant determinant
of CAD risk or its severity.
Keywords :
Coronary artery disease , Prothrombin , Coronary angiography , Single-nucleotide polymorphism